Based on Q3 report and the 'finalisation' of customer trials of Spenda products, I'm inclined to believe that the uptake from trial participants;- was not strong, or- the participants with relatively significant revenue did not sign on after the trial ended.It is odd that the company has not made any further announcements post the Q3 report to update on its strategic accomplishments, customer and emerging market growth, and operations hubs in Australia, India and Singapore.
Ann: Issue of Shares in lieu of Net Salary, page-157
-
- There are more pages in this discussion • 95 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.24M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.0¢ | 1.0¢ | $4.104K | 410.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 3219998 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 649583 | 3 |
View Market Depth
| Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
| SPX (ASX) Chart |